Actively Recruiting
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
Led by First Affiliated Hospital of Fujian Medical University · Updated on 2021-03-22
2000
Participants Needed
1
Research Sites
2086 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.
CONDITIONS
Official Title
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Amyotrophic lateral sclerosis patients fulfilling the El Escorial criteria (including definite, probable and possible)
- Progressive muscular atrophy
- Primary lateral sclerosis
- Progressive bulbar palsy
You will not qualify if you...
- History of serious head trauma or neuropsychiatric disease
- Decline to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology, First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350005
Actively Recruiting
Research Team
Q
Qi-Jie Zhang, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here